We take an in-depth look at the benefits and risk factors of statin use for people with type 1 diabetes.
Springtime...It's a great time to check your diabetes technology coverage options!
We wanted to let you know about a recent acronym change you will be seeing from the educators at IDS.
Novonordisk announced an additional indication for their GLP-1 medications Ozempic to “reduce the risk of major adverse cardiovascular events such as heart attack, stroke or death in adults with type 2 diabetes and known heart disease."
A new study discusses the correlation between type 1 and 2 diabetes and cancer and identifies which has more risk.
2 weeks on Control IQ – too soon to call? Our newest Hybrid Closed Loop showing a lot of promise… if you know how to work it.
How the holidays can be a great time for diabetes awareness.
Diabetes Management: Saving up for a rainy day, could leave you out in the storm.
Murphy's Law: Whatever can go wrong, will go wrong
Baqsimi Nasal glucagon gives people with diabetes a new option, but don’t abandon the needle!
FDA approves Eyelea in all forms of Diabetes related retinopathy
Why get involved? The benefits of diabetes advocacy are outward and inward!
Copays, Caps and Cost Savings: A look at recent "apparent" efforts to reduce the cost of living with diabetes.
Alicia: UnLeashed! may 2019 article covers How Diabetes care and management is changing in 2019.
List of services that are covered by most private insurance as well as Medicare and most, if not all Medicaid MCOs.